Niagen Bioscience, Inc. — Director's Dealing 2021

Apr 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC)
CIK: 0001386570
Period of Report: 2020-04-17

Reporting Person: Fried Robert N (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-17	Common Stock	G	500000	—	Disposed	882561	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	250000	Indirect
Common Stock	250000	Indirect
Common Stock	53001	Indirect
Common Stock	9753	Indirect
Common Stock	12746	Indirect

Footnotes

F1: On April 17, 2020, the Reporting Person transferred an aggregate of 500,000 shares to trusts established for the benefit of his children as follows: 250,000 shares to US Trust Company of Delaware Trustee of The Benjamin A Fried 2020 Irrevocable Trust dated 02/26/2020 and 250,000 shares to US Trust Company of Delaware Trustee of The Jeremy W Fried 2020 Irrevocable Trust dated 02/26/2020.

F2: 1,000 shares held by the Reporting Person were inadvertently reported on a prior Form 4 filing as held directly. Instead, the shares are held by the Reporting Person indirectly in the name of the Fried-Travis Revocable Trust U/A Dated 06/02/1999.

F3: 9,753 shares held by the Reporting Person were inadvertently reported on prior Form 4 filings as held directly. Instead, the shares are held by the Reporting Person indirectly in the name of Fried Films Profit Sharing.

F4: 6,745 shares held by Jeremy Fried and 6,001 shares held by Benjamin Fried, who are sons of Robert Fried.